ATNF Research and Charts

ATNF - 180 Life Sciences Corp Ordinary Shares (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2026-02-05)

Last 3.10	Change ⇓ -0.38 (-10.92%)	Volume 794,024
	Open 3.27	High 3.40	Low 3.01

8EMA (Daily) 3.96	40EMA (Daily) 5.83	50EMA (Daily) 6.23	STO (Daily) 4.378	MACD Hist (Daily) -0.133
8EMA (Weekly) 5.343	40EMA (Weekly) 5.71	50EMA (Weekly) 6.21	STO (Weekly) 7.004	MACD Hist (Weekly) -0.975


Company Profile
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.